Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

Overview of attention for article published in Clinical Cancer Research, February 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 35 news stories from 24 outlets.

A- A+ SAR441000 (BTN131)：是一种免疫刺激mRNA混合物，编码IL-12sc、IL-15、IFN-α和粒细胞-巨噬细胞集落刺激因子GMCSF。目前仅公布了首次人体试验的剂量安全性检测阶段结果。瘤内(Intratumoral, IT)免…

High Impact Peer-Reviewed Medical Journal Highlights Overall Response Rate of 35.7% and Complete Response of 17.9% with…

/PRNewswire/ --OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage…

SAN DIEGO and PENNINGTON, N.J., March 17, 2020 /PRNewswire/ -- OncoSec Medical Inc.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 31 additional news stories.